Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Morning Review
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
    • Insider Transactions
  • inderesTV
  • Portfolio
  • Forum
  • Premium
  • Femme
  • Nora AI
  • Learn
    • Investing School
    • Q&A
    • Analysis School
  • About Us
    • Our Coverage
    • Team
Regulatory press release

Magnasense appoints Vicki Johnson as interim CFO

Subgen AI
Download the release

Magnasense today announced the appointment of Vicki Johnson as interim Chief Financial Officer (CFO), succeeding Christel Dahlberg, who has resigned today due to private health reasons.

Vicki Johnson brings extensive experience in finance to her new role. She holds a Master's Degree in Chemistry from Oxford University and began her career at EY LLP, where she qualified as a Chartered Accountant (CA). Vicki has held various finance roles across professional services, manufacturing, and technology sectors, with expertise in financial reporting, audit, budgeting, forecasting, tax, and treasury.

For the past five years, Vicki Johnson has been a financial consultant with CFPro Limited (now part of BKL) in the UK, providing CFO services to a FTSE AIM-listed manufacturing company and a privately owned technology company.

"We are grateful to Christel Dahlberg for her contributions to Magnasense and wish her the best," said CEO Marco Witteveen. "We are confident that Vicki Johnson's leadership will guide Magnasense through this transition and advance our financial strategy."

"I am honored to step into the role of interim CFO at Magnasense," said Vicki Johnson. "I look forward to working with the executive team to drive our strategic goals and contribute to our future success."

Vicki Johnson has been appointed interim CFO starting immediately, while the recruitment of a new CFO is ongoing. The board and executive team are committed to ensuring a smooth transition and continued excellence in financial management.

For additional information, please contact:
Marco Witteveen, CEO, Magnasense AB
Email: ir@magnasense.com
The Company’s Certified Adviser is Eminova Fondkommission AB | adviser@eminova.se

About Magnasense AB
Magnasense is a Swedish diagnostics company founded in 2019 to offer tests to monitor and optimize the dosage of biological drugs via its unique patented technology platform. In June 2020, Magnasense was listed on the Nasdaq First North Growth Market. The company's ambition is, in addition to bringing innovative diagnostic technology to the market, to make diagnostics more accessible, easier to use and to provide accurate and easily transferable results. For more information, see Magnasense's website www.magnasense.com.

Attachments
Magnasense appoints Vicki Johnson as interim CFO

Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • Instagram
  • X (Twitter)
  • Tiktok
  • Linkedin
Get in touch
  • info@inderes.fi
  • +358 10 219 4690
  • Porkkalankatu 5
    00180 Helsinki
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.